{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:39:28Z","timestamp":1781195968025,"version":"3.54.1"},"reference-count":30,"publisher":"The Journal of Rheumatology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>There is little information about the epidemiology and factors associated with opioid therapy in systemic lupus erythematosus (SLE). We aimed to assess the prevalence of opioid therapy and explore factors associated with long-term opioid therapy (LTOT) in patients with SLE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with SLE were matched with controls without SLE in a population-based cohort on January 1, 2015. We captured demographics, manifestations of SLE, comorbidities (ie, fibromyalgia, mood disorders, osteoarthritis, chronic low back pain [CLBP], chronic kidney disease (CKD), avascular necrosis, osteoporosis, fragility fractures, and cancer), and the Area Deprivation Index (ADI). Opioid prescription data were used to assess the prevalence of LTOT, defined as contiguous prescriptions (gaps of &lt; 30 days between prescriptions) and receiving opioid therapy for \u2265 90 days or \u2265 10 prescriptions before the index date.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 465 patients with SLE and 465 controls without SLE were included. In total, 13% of patients with SLE and 3% of controls without SLE were receiving opioid therapy (<jats:italic>P<\/jats:italic>&lt; 0.001), and 11% of patients with SLE were on LTOT vs 1% of controls without SLE. Among patients with SLE, acute pericarditis (odds ratio [OR] 3.92, 95% CI 1.78-8.66), fibromyalgia (OR 7.78, 95% CI 3.89-15.55), fragility fractures (OR 3.72, 95% CI 1.25-11.07), CLBP (OR 4.00, 95% CI 2.13-7.51), and mood disorders (OR 2.76, 95% CI 1.47-5.16) were associated with LTOT. We did not find an association between opioid therapy and ADI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with SLE are more likely to receive LTOT than controls. Among patients with SLE, LTOT was associated with pericarditis and several comorbidities. However, LTOT was not associated with CKD despite the limited pain control options among these patients.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.220822","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T13:20:23Z","timestamp":1668518423000},"page":"504-511","source":"Crossref","is-referenced-by-count":11,"title":["Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study"],"prefix":"10.3899","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6077-8899","authenticated-orcid":false,"given":"Gabriel","family":"Figueroa-Parra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3854-6810","authenticated-orcid":false,"given":"Molly M.","family":"Jeffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse Y.","family":"Dabit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9646-7603","authenticated-orcid":false,"given":"Baptiste","family":"Chevet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria O.","family":"Valenzuela-Almada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Hocaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley-Ann","family":"Osei-Onomah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2366-7505","authenticated-orcid":false,"given":"Shaheen","family":"Kurani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-6355","authenticated-orcid":false,"given":"W. Michael","family":"Hooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0546-6742","authenticated-orcid":false,"given":"Kamil E.","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-7475","authenticated-orcid":false,"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-5719","authenticated-orcid":false,"given":"Al\u00ed","family":"Duarte-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"2023122109250650000_50.4.504.1","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2023122109250650000_50.4.504.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30546-X"},{"key":"2023122109250650000_50.4.504.3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.rdc.2020.12.004","article-title":"The categorization of pain in systemic lupus erythematosus","volume":"47","author":"Pisetsky","year":"2021","journal-title":"Rheum Dis Clin North Am"},{"key":"2023122109250650000_50.4.504.4","doi-asserted-by":"publisher","DOI":"10.1191\/096120301668183556"},{"key":"2023122109250650000_50.4.504.5","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6501e1"},{"key":"2023122109250650000_50.4.504.6","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6838a2"},{"key":"2023122109250650000_50.4.504.7","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000435"},{"key":"2023122109250650000_50.4.504.8","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq482"},{"key":"2023122109250650000_50.4.504.9","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx268"},{"key":"2023122109250650000_50.4.504.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.11.009"},{"key":"2023122109250650000_50.4.504.11","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys195"},{"key":"2023122109250650000_50.4.504.12","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2023122109250650000_50.4.504.13","doi-asserted-by":"publisher","DOI":"10.1136\/jamia.2009.001289"},{"key":"2023122109250650000_50.4.504.14","first-page":"1089","article-title":"Using RxNorm and NDF-RT to classify medication data extracted from electronic health records: experiences from the Rochester Epidemiology Project","volume":"2011","author":"Pathak","year":"2011","journal-title":"AMIA Annu Symp Proc"},{"key":"2023122109250650000_50.4.504.15","unstructured":"U.S. Department of Health & Human Services: Guidance Portal . Opioid Oral Morphine Milligram Equivalent (MME) Conversion Factors table for prescription drug coverage. [Internet. Accessed September 7, 2022.] Available from: https:\/\/www.hhs.gov\/guidance\/document\/opioid-oral-morphine-milligram-equivalent-mme-conversion-factors."},{"key":"2023122109250650000_50.4.504.16","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2023122109250650000_50.4.504.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1802313"},{"key":"2023122109250650000_50.4.504.18","doi-asserted-by":"crossref","first-page":"e200618","DOI":"10.1001\/jamanetworkopen.2020.0618","article-title":"Association of neighborhood measures of social determinants of health with breast, cervical, and colorectal cancer screening rates in the US Midwest","volume":"3","author":"Kurani","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2023122109250650000_50.4.504.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027495"},{"key":"2023122109250650000_50.4.504.20","unstructured":"Centers for Disease Control and Prevention . U.S. opioid dispensing rate maps. [Internet. Accessed September 7, 2022.] Available from: https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html."},{"key":"2023122109250650000_50.4.504.21","first-page":"23","article-title":"Opioid dispensation among systemic lupus erythematosus patients who persistently frequent the emergency department","volume":"16","author":"Lee","year":"2019","journal-title":"J Opioid Manag"},{"key":"2023122109250650000_50.4.504.22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00393-021-00971-y","article-title":"Prescription of analgesics in patients with rheumatic diseases in Germany: a claims data analysis","volume":"80","author":"Albrecht","year":"2021","journal-title":"Z Rheumatol"},{"key":"2023122109250650000_50.4.504.23","doi-asserted-by":"crossref","first-page":"e0221153","DOI":"10.1371\/journal.pone.0221153","article-title":"Opioid prescription patterns in Germany and the global opioid epidemic: systematic review of available evidence","volume":"14","author":"Rosner","year":"2019","journal-title":"PLoS One"},{"key":"2023122109250650000_50.4.504.24","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2011.06.100232"},{"key":"2023122109250650000_50.4.504.25","doi-asserted-by":"crossref","first-page":"e0220216","DOI":"10.1371\/journal.pone.0220216","article-title":"An updated analysis of opioids increasing the risk of fractures","volume":"15","author":"Yue","year":"2020","journal-title":"PLoS One"},{"key":"2023122109250650000_50.4.504.26","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/AJP.0000000000000603","article-title":"Depression effects on long-term prescription opioid use, abuse, and addiction","volume":"34","author":"Sullivan","year":"2018","journal-title":"Clin J Pain"},{"key":"2023122109250650000_50.4.504.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.02.002"},{"key":"2023122109250650000_50.4.504.28","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm655051e1"},{"key":"2023122109250650000_50.4.504.29","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1243"},{"key":"2023122109250650000_50.4.504.30","doi-asserted-by":"crossref","first-page":"e2116860","DOI":"10.1001\/jamanetworkopen.2021.16860","article-title":"Changes in initial opioid prescribing practices after the 2016 release of the CDC guideline for prescribing opioids for chronic pain","volume":"4","author":"Goldstick","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.220822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T17:25:57Z","timestamp":1703179557000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.220822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,1]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.3899\/jrheum.220822"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.220822","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]}}}